Charles Schwab’s Baker Hughes BKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $478M | Buy |
8,614,262
+524,003
| +6% | +$33.1M | 0.06% | 248 |
|
|
2026
Q1 | $494M | Buy |
8,090,259
+222,336
| +3% | +$12.9M | 0.08% | 220 |
|
|
2025
Q4 | $358M | Buy |
7,867,923
+189,711
| +2% | +$9M | 0.06% | 275 |
|
|
2025
Q3 | $374M | Buy |
7,678,212
+220,039
| +3% | +$9.71M | 0.06% | 267 |
|
|
2025
Q2 | $286M | Buy |
7,458,173
+183,681
| +3% | +$6.93M | 0.05% | 309 |
|
|
2025
Q1 | $320M | Buy |
7,274,492
+187,589
| +3% | +$8.37M | 0.06% | 261 |
|
|
2024
Q4 | $291M | Buy |
7,086,903
+135,200
| +2% | +$5.45M | 0.05% | 286 |
|
|
2024
Q3 | $251M | Buy |
6,951,703
+22,383
| +0.3% | +$787K | 0.05% | 312 |
|
|
2024
Q2 | $244M | Buy |
6,929,320
+161,766
| +2% | +$5.31M | 0.05% | 326 |
|
|
2024
Q1 | $227M | Buy |
6,767,554
+109,312
| +2% | +$3.37M | 0.05% | 317 |
|
|
2023
Q4 | $228M | Buy |
6,658,242
+204,839
| +3% | +$6.99M | 0.06% | 292 |
|
|
2023
Q3 | $228M | Buy |
6,453,403
+57,803
| +0.9% | +$2.05M | 0.07% | 262 |
|
|
2023
Q2 | $202M | Buy |
6,395,600
+222,501
| +4% | +$6.49M | 0.06% | 290 |
|
|
2023
Q1 | $178M | Buy |
6,173,099
+180,521
| +3% | +$5.46M | 0.05% | 314 |
|
|
2022
Q4 | $177M | Buy |
5,992,578
+44,630
| +0.8% | +$1.23M | 0.06% | 311 |
|
|
2022
Q3 | $125M | Buy |
5,947,948
+404,743
| +7% | +$10.1M | 0.04% | 365 |
|
|
2022
Q2 | $160M | Buy |
5,543,205
+130,088
| +2% | +$4.4M | 0.06% | 312 |
|
|
2022
Q1 | $197M | Buy |
5,413,117
+328,823
| +6% | +$9.98M | 0.06% | 303 |
|
|
2021
Q4 | $122M | Buy |
5,084,294
+330,362
| +7% | +$8.16M | 0.04% | 449 |
|
|
2021
Q3 | $118M | Buy |
4,753,932
+769,752
| +19% | +$17.1M | 0.04% | 425 |
|
|
2021
Q2 | $91.1M | Buy |
3,984,180
+52,218
| +1% | +$1.21M | 0.03% | 533 |
|
|
2021
Q1 | $85M | Sell |
3,931,962
-1,130,343
| -22% | -$25.7M | 0.03% | 532 |
|
|
2020
Q4 | $106M | Buy |
5,062,305
+75,034
| +2% | +$1.32M | 0.04% | 396 |
|
|
2020
Q3 | $66.3M | Sell |
4,987,271
-61,891
| -1% | -$947K | 0.03% | 506 |
|
|
2020
Q2 | $77.7M | Buy |
5,049,162
+25,992
| +0.5% | +$380K | 0.04% | 438 |
|
|
2020
Q1 | $52.7M | Buy |
5,023,170
+446,464
| +10% | +$8.39M | 0.03% | 505 |
|
|
2019
Q4 | $117M | Buy |
4,576,706
+223,888
| +5% | +$5.09M | 0.06% | 280 |
|
|
2019
Q3 | $101M | Buy |
4,352,818
+937,956
| +27% | +$22M | 0.06% | 298 |
|
|
2019
Q2 | $84.1M | Buy |
3,414,862
+223,750
| +7% | +$5.4M | 0.05% | 357 |
|
|
2019
Q1 | $88.5M | Buy |
3,191,112
+981,349
| +44% | +$24.8M | 0.06% | 316 |
|
|
2018
Q4 | $47.5M | Buy |
2,209,763
+318,778
| +17% | +$8.14M | 0.04% | 472 |
|
|
2018
Q3 | $64M | Sell |
1,890,985
-67,328
| -3% | -$2.23M | 0.04% | 408 |
|
|
2018
Q2 | $64.7M | Sell |
1,958,313
-57,707
| -3% | -$1.96M | 0.05% | 389 |
|
|
2018
Q1 | $56M | Sell |
2,016,020
-49,331
| -2% | -$1.51M | 0.04% | 422 |
|
|
2017
Q4 | $65.3M | Buy |
2,065,351
+98,233
| +5% | +$3.15M | 0.05% | 339 |
|
|
2017
Q3 | $72M | Buy |
+1,967,118
| New | +$69.8M | 0.06% | 296 |
|
Other funds holding BKR
Charles Schwab's BKR Position: Q2 2026 in Review
Charles Schwab increased its Baker Hughes (BKR) stake by 6.5% in Q2 2026, buying an estimated $33.1M and bringing the position to 8,614,262 shares worth $478M. The position accounts for 0.06% of the portfolio, ranked #248.
Charles Schwab first reported a position in BKR in Q3 2017 and has held it in 36 quarters since. The position peaked at $494M in Q1 2026. 1,143 funds tracked by Wall St. Rank hold BKR as of Q2 2026.
- Charles Schwab held 8,614,262 shares of Baker Hughes worth $478M as of Q2 2026.
- Charles Schwab bought 524,003 Baker Hughes shares in Q2 2026, an estimated $33.1M.
- Baker Hughes made up 0.06% of Charles Schwab's portfolio in Q2 2026, its #248 holding.
- Charles Schwab first reported a position in Baker Hughes in Q3 2017 and has held it in 36 quarters since.
- Charles Schwab's Baker Hughes position peaked at $494M in Q1 2026.
- 1,143 funds tracked by Wall St. Rank held Baker Hughes as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.